Clinical Trial Update: Effect of Maraviroc on Endothelial Function in HIV-Infected Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the effect of maraviroc on endothelial function in HIV-infected patients. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Human Immunodeficiency Virus Infection
• Inflammation

Drugs mentioned

• Maraviroc (maraviroc)

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV Infection, Cardiovascular Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-06-19